Navigation Links
Treatment for Prescription Drug Addiction and Painkiller Abuse has Risen Sharply Since Onset of Financial Crisis, Reflecting Uncertainty About Economy

MALIBU, Calif., Feb. 9, 2011 /PRNewswire/ -- The 2007 onset of the financial crisis that upended the U.S. economy and impacted global markets correlated closely with unprecedented numbers of patients seeking treatment for prescription drug addiction and painkiller abuse, according to leading rehabilitation center Cliffside Malibu. The Cliffside Index, the percentage of patients admitted for treatment related to those medications, rose over 60 percent between 2007 and 2008, and has continued to increase each year.

Beginning in 2007, a growing number of patients began expressing heightened states of uncontrollable anxiety about the economy, reported the physicians and other mental and physical health experts who oversee rigorous protocols of daily therapy sessions at the highly regarded facility.  However, leveling off of patient admissions for abuse of painkillers and prescription drugs at the end of 2010 year may signal that the economy is stabilizing or that this is the U.S. public's perception.

Key Findings from Cliffside Malibu's Review:

  • The increase in the proportion of patients seeking treatment for prescription drug and painkiller addiction unrelated to injury has increased 143% since 2005 (from 21.8% to 52.9%). 

  • The largest yearly increase in proportion of patients seeking treatment for prescription drug and painkiller addiction was 60.1% from 2007 to 2008 (at start of the economic crisis)

  • Xanax is by far the most abused substance among patients admitted for treatment of prescription medication addiction (60% of cases), followed by Klonopin and Oxycontin.

  • Beginning in 2007, increasing numbers of patients cited the country's financial situation as a major cause of elevated anxiety levels.

  • Leveling off of patient admissions for painkillers and other prescription drug abuse suggests the economy may be turning around  

"People recovering from substance addiction at Cliffside are apparently beginning to feel that the economy is showing signs of recovery," said Richard Taite, Chief Executive Officer of Cliffside Malibu.  "I anticipate that in 2011 we will see a reduction in the proportion of admitted patients seeking treatment for dependence on prescription drugs."

Dr. Georgina Smith, Program Director of Cliffside Malibu adds, "In recent years we have noticed a higher percentage of our patients expressing anxiety over the state of the economy, and we have treated a record high number of people addicted to prescription pills, which can be misused to mask feelings of anxiety."

About Cliffside Malibu

Cliffside Malibu is a full-service residential drug abuse, painkiller addiction and alcohol addiction treatment center in the Los Angeles area. At Cliffside, teams of highly trained experts administer individually tailored rehabilitation programs for every type of addiction to patients who place a premium on privacy, safety, and, most importantly, effectiveness.  The drug rehab facility gets its name from its striking location on a hill overlooking the Pacific Ocean.  For more information, visit or call 800 501 1988.  

SOURCE Cliffside Malibu
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reportlinker Adds Global Physician Survey on Stents, Stent-Grafts and Vulnerable Plaque Treatment 2011
2. Cancer Patients in Bangladesh Gain Access to Advanced RapidArc Radiotherapy Treatments from Varian Medical Systems
3. FDA Approves Makena™, the First and Only Treatment to Reduce the Risk of Preterm Birth in Women With a Singleton Pregnancy Who Have a History of Singleton Spontaneous Preterm Birth
4. FDA Grants Orphan Drug Designation to Bayers Investigational Compound Regorafenib for the Treatment of Gastrointestinal Stromal Tumors
5. CardioVascular BioTherapeutics Submits FDA Application for Fast Track Status for CVBT-141B, CVBTs Biological Treatment for Diabetes Patients
6. Effective Treatment of Lyme Disease-Related Arthritis Depends on Proper Diagnosis
7. San Antonios Texas Institute of Dermatology, Laser and Cosmetics Adds Alma Lasers Harmony XL Cosmetic Laser to Offer Advanced Rejuvenation Treatments to Patients
8. BioMarin Initiates Pivotal Phase 3 Trial for GALNS for the Treatment of MPS IVA
9. Lakewood-Amedex Inc. Receives Notice of Allowance on Three US Patent Applications Relating to Treatment of Hemolytic Uremic Syndrome
10. Mylans Matrix Obtains License for Promising HIV/AIDS Treatment
11. Tibotec Signs Multiple Agreements With Generic Manufacturers to Provide Access to New HIV Treatment
Post Your Comments:
(Date:11/25/2015)... Nov. 25, 2015 USP 800 applies ... preparations (e.g. pharmacists, pharmacy technicians, nurses, physicians, physician ... The chapter also covers all entities which store, ... hospitals, other healthcare institutions, patient treatment clinics, physicians, ... --> --> What is the ...
(Date:11/25/2015)... Nov. 25, 2015  Mindray Medical ... MR ), a leading developer, ... worldwide, today announced that it will ... of shareholders at the Company,s Hong Kong office ... Prince Edward West Road, Mongkok KL, Hong ...
(Date:11/25/2015)... 2015 Research and Markets ( ) ... - Global Forecast to 2020" report to their ... for 37.21% of the total market share in 2014. ... region is projected to growth at the highest CAGR ... primarily to the fast growing water, industrial gas treatment, ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... November 25, 2015 , ... In an ongoing Clinical Study conducted ... in Chicago, IL, UV Angel is evaluating the efficacy of its product and its ... units (totaling 30 beds) from May 2014 through October 2015 at a 360-bed, acute-care, ...
(Date:11/25/2015)... LOUIS, Missouri (PRWEB) , ... November 25, 2015 ... ... Project HEAL, will provide scholarships for people struggling with eating disorders as a ... Proceeds from the second annual event, held at Fox Run Golf Club in ...
(Date:11/25/2015)... ... November 25, 2015 , ... Privately owned Contract Development ... expansion of its current state of the art research, development and manufacturing facility ... increase its manufacturing capacity as well as to support its clients’ growing research ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... Sclerosis Complex (TSC), as well as raising public awareness of the disorder while ... it—presented a third donation of $35,000 to bolster progress at the Tuberous Sclerosis ...
(Date:11/25/2015)... ... November 25, 2015 , ... Bunion Bootie , ... early celebration of the early holiday shopping season. Starting Wednesday November 25th, Bunion ... ea). Black Friday promotional pricing is in addition to any automatic discounts applied ...
Breaking Medicine News(10 mins):